Study of maternal serum lipid profile and apolipoprotein a levels and its correlation with fetal growth restriction

Akoijam Tamphasana Devi, Reena Yadav, Amita Yadav, Yanglem Ajitkumar Singh


Background: This study was aimed to estimate maternal serum lipid profile and apolipoprotein A levels in pregnancies complicated with FGR and to compare the levels with the levels in normal pregnancies.

Methods: A prospective observational study was conducted in Lady Hardinge Medical College, New Delhi, in a study group consisting of 30 pregnant women at gestation 32-34 weeks with ultrasound diagnosed FGR and control group consisting of 30 age and gestation matched uncomplicated pregnant women. Maternal serum lipid profile and apolipoprotein A levels were measured and compared between the two groups.

Results: Total serum cholesterol, triglyceride, LDL-cholesterol, VLDL-cholesterol and Apolipoprotein A were significantly lower in FGR group compared to normal controls. Mean±SD of total cholesterol was found to be 199.17±49.06 mg/dl in cases and 244.10±53.17 mg/dl in controls. Mean±SD of triglyceride was 200.53±60.25 mg/dl in cases compared to 304.13±69.12 mg/dl in controls. Mean±SD of LDL-Cholesterol was 98.19±37.91 mg/dl in cases and 127.07±47.84 mg/dl in controls. Mean±SD of VLDL-cholesterol was 40.11±12.05 mg/dl in cases and 60.83±13.82 mg/dl in controls. Mean±SD of Apolipoprotein A was 147.71±16.40 mg/dl in cases compared to 163.30±16.07 mg/dl in controls. HDL-cholesterol did not change significantly as its mean±SD was 60.87±15.18 mg/dl in FGR group and 56.20±16.07 mg/dl in control group.

Conclusions: The decreased levels of total cholesterol, triglyceride, LDL-cholesterol, VLDL-cholesterol and apolipoprotein A levels may be used as biochemical marker for detection of FGR.


Apolipoprotein A, Cholesterol, Fetal growth restriction, Triglyceride

Full Text:



Bernstein I, Gabbe SG. Intrauterine growth restriction. In: Gabbe SG, Niebyl JR, Simpson JL, Annas GJ, et al (Eds). Obstetrics: Normal and Problem Pregnancies. New York: Churchill Livingstone; 1996;3:863-86.

Wolf HM, Gross TL. Increased risk to the growth retarded fetus. In: Gross TL, Sokol RJ, (Eds). Intauterine Growth Retardation: a practical approach. Chicago: Year Book Medical Publishers; 1989: 111-124.

Creasy RK, Resnik R. Intrauterine growth restriction. In: Creasy RK, Resnik R (Eds). Maternal Fetal Medicine: Principles and Practice. Philadelphia: Saunders. 1994;3:558-74.

Battaglia FC, Lubchenco LO. A practical classification of newborn infants by weight and gestational age. J Pediatr. 1967;71:159-63.

Dabi DR, Parakh M, Goyal V. A cross sectional study of lipids and lipoproteins in pregnancies with intrauterine growth retardation. J Obstet Gynecol. 2004;54(5):467-72.

Munoz A, Uberos J, Molina A, Valenzuela A, Cano D, Cruiz C, et al. Relationship of blood rheology to lipoprotein profile during normal pregnancies and those with intrauterine growth restriction. J Clin Pathol. 1995;48:571-4.

Rodie VA, Caslake MJ, Stewart F, Sattar N, Ramsay JE, Greer IA, et al. Fetal cord plasma lipoprotein status in uncomplicated human pregnancies and pregnancies complicated by pre-eclampsia and intrauterine growth restriction. Atheroscl. 2004;176:181-7.

Herrera E. Lipid metabolism in pregnancy and its consequences in the foetus and newborn. Endocrine. 2000;19:43-55.

Miranda J, Simoes RV, Pauls C. Metabolic profiling and targeted lipidomics reveals a disturbed lipid profile in mothers and foetuses with intrauterine growth restriction. Scientific Reports. 2018;8:13614.

Sattar N, Ian AG, Peter JG, Chris JP, James S, Theresa K, et al. Lipid and Lipoprotein concentrations in pregnancies complicated by intrauterine growth restriction. J Clin Endocrinol Metabol. 1999;84(1):128-30.

Bea JG, Park JC. Rhee JH, Kim JI. Comparison of plasma lipids and lipoprotein concentrations in normal and intrauterine growth restriction pregnancies. Korean J Obstet Gynecol. 2009;52(4):400-6.

Contini C, Winkler BS, Maass N, Alkatout I, Winkler K, Pecks U. Concomitant intrauterine growth restriction alters the lipoprotein profile in preelampsia. Preg Hyper. 2019;15:154-60.

Borna S. Relationship between amniotic fluid and maternal lipid profiles for predicting pregnancy outcome. Ultrasound Obstet Gynecol. 2016;48(1):336.

Tana GMV, Nathalie K, Barbara A. Maternal lipid profile during early pregnancy and pregnancy complications and outcomes: the ABCD Study. J Clin Endocrinol Metab. 2012;97(11):3917-25.